Buformin suppresses osteosarcoma via targeting AMPK signaling pathway.
Ding Y, Lv S, Li G, Cui J, Chen Y.
Open Life Sci · other; journal article · DOI 10.1515/biol-2020-0041 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för buformin. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
20 träffarPostmortem distribution/redistribution of buformin in body fluids and solid tissues in an autopsy case using liquid chromatography-tandem mass spectrometry with QuEChERS extraction method.
Wurita A, Hasegawa K, Nozawa H, Yamagishi I, Minakata K, Watanabe K, Suzuki O.
Forensic Sci Int · journal article; case reports · DOI 10.1016/j.forsciint.2020.110376The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells.
Yakisich JS, Azad N, Kaushik V, Iyer AKV.
Stem Cells Int · research-article; journal article · DOI 10.1155/2019/6254269Buformin increases radiosensitivity in cervical cancer cells via cell-cycle arrest and delayed DNA-damage repair.
Chen L, Zhang T, Liu Q, Tang M, Yang Y, Wang Y, Qiu H, Yu J.
Exp Biol Med (Maywood) · research-article; journal article · DOI 10.1177/1535370218813320Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
Li J, Chen L, Liu Q, Tang M, Wang Y, Yu J.
Cancer Biol Ther · research-article; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1080/15384047.2018.1433504Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.
Parris AB, Zhao Q, Howard EW, Zhao M, Ma Z, Yang X.
J Exp Clin Cancer Res · research-article; journal article · DOI 10.1186/s13046-017-0498-0The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.
Ohnishi S, Mizutani H, Kawanishi S.
Free Radic Res · journal article · DOI 10.1080/10715762.2016.1204651Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
Kilgore J, Jackson AL, Clark LH, Guo H, Zhang L, Jones HM, Gilliam TP, Gehrig PA, Zhou C, Bae-Jump VL.
Am J Transl Res · research-article; journal articleEffects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
Zhu Z, Jiang W, Thompson MD, Echeverria D, McGinley JN, Thompson HJ.
Cancer Prev Res (Phila) · research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1940-6207.capr-14-0121Sensitive determination of buformin using poly-aminobenzoic acid modified glassy carbon electrode.
Jin GY, Li H, Xu WB.
J Pharm Anal · brief-report; journal article · DOI 10.1016/j.jpha.2012.05.005Buformin suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase.
Yano A, Kubota M, Iguchi K, Usui S, Hirano K.
Biol Pharm Bull · journal article · DOI 10.1248/bpb.29.1006Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Kiho T, Kato M, Usui S, Hirano K.
Clin Chim Acta · journal article · DOI 10.1016/j.cccn.2005.02.012A validated HPLC method with ultraviolet detection for the determination of buformin in plasma.
Chou CH, Cheng CL, Huang CC.
Biomed Chromatogr · research support, non-u.s. gov't; journal article · DOI 10.1002/bmc.312[Lactic acidosis associated with buformine use].
Montero Alonso M, Salvador Cervelló G, Perelló Roso A, Roig Osca MA.
Rev Clin Esp · letter; case reports · DOI 10.1157/13045547Insulin and longevity: antidiabetic biguanides as geroprotectors.
Anisimov VN, Semenchenko AV, Yashin AI.
Biogerontology · research support, non-u.s. gov't; journal article · DOI 10.1023/a:1026299318315A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.
Yamamoto T, Kusama M, Matsuno K, Sugiyama E, Yamada Y, Iga T.
Biomed Chromatogr · journal article · DOI 10.1002/bmc.182Acrylic microspheres for oral controlled release of the biguanide buformin.
Fundueanu G, Mocanu G, Constantin M, Carpov A, Bulacovschi V, Esposito E, Nastruzzi C.
Int J Pharm · journal article · DOI 10.1016/s0378-5173(01)00570-1[Lactic acidosis and buformin].
Blasco Navalpotro MA, Zaragoza Crespo R, Olivares Toledo D, Alamán Laguarda G.
Rev Clin Esp · letter; case reports[Lactic acidosis in diabetic patients associated with buformin].
García de los Ríos M.
Rev Med Chil · letter; comment; english abstract[Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
Ziegelasch HJ.
Z Gesamte Inn Med · journal article